Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Pharmacol Res. 2019 Sep 10;148:104452. doi: 10.1016/j.phrs.2019.104452

Fig. 3.

Fig. 3.

Supernatant NO2− levels are increased following LPS or PBI1 treatment as measured by Griess assay. Pretreatment with TAK242 inhibited TLR4 activity prior to PBI1 addition (PBI1 + TAK242). Unpaired, two-tailed student T-tests with equal variance were used to determine significance; **P ≤ 0.005, ***P ≤ 0.0005, ****P ≤ 0.00005. n.s. = non-significant.